The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

Files
CTS-10-143.pdf (175.6 KB)
Date
2017-05
Authors
Cavallari, LH
Beitelshees, AL
Blake, KV
Dressler, LG
Duarte, JD
Elsey, A
Eichmeyer, JN
Empey, PE
Franciosi, JP
Hicks, JK
Holmes, AM
Jeng, LJB
Lee, CR
Lima, JJ
Limdi, NA
Modlin, J
Obeng, AO
Petry, N
Pratt, VM.
Skaar, Todd C.
Tuteja, S
Voora, D
Wagner, M
Weitzel, KW
Wilke, RA
Peterson, JF
Johnson, JA
Language
American English
Embargo Lift Date
Department
Health Policy and Management, School of Public Health
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Abstract
Description
Keywords
Genotype, US Food and Drug Administration, drug response, CPIC, IGNITE
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Cavallari, L., Beitelshees, A., Blake, K., Dressler, L., Duarte, J., Elsey, A., … Johnson, J. (2017). The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting. Clinical and Translational Science, 10(3), 143–146. https://doi.org/10.1111/cts.12456
ISSN
1752-8054
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical and Translational Science
Rights
Attribution-NonCommercial-NoDerivs 3.0 United States Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/16320
DOI
https://doi.org/10.1111/cts.12456
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Health Policy and Management Works
Todd Skaar